Vicore Pharma Holding AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	470.06	1,156	333.62	256.8	294.2	248.62
Short-Term Investments	365.78	-	149.15	4.94	77.28	70.12
Cash & Short-Term Investments	835.84	1,156	482.77	261.74	371.48	318.74
Cash Growth	119.71%	139.45%	84.44%	-29.54%	16.55%	20.45%
Other Receivables	6.14	19.76	3.13	2.18	1.42	8.51
Receivables	6.14	19.76	3.13	2.18	1.42	8.51
Prepaid Expenses	23.34	27.35	9.7	5.87	5.03	0.61
Total Current Assets	865.31	1,203	495.6	269.79	377.93	327.85
Property, Plant & Equipment	-	-	0.03	0.12	0.4	0.25
Long-Term Investments	-	-	-	-	5.41	7.53
Other Intangible Assets	-	-	2.22	68.1	67.43	70.76
Long-Term Deferred Tax Assets	-	-	-	-	-	0.13
Other Long-Term Assets	1.41	-	-	-	-	-
Total Assets	866.72	1,203	497.84	338.01	451.17	406.52
Accounts Payable	14.79	29.97	17.92	23.5	23.98	10.94
Accrued Expenses	40.78	22.97	14.65	18.22	40.14	29.53
Current Portion of Leases	-	-	-	0.07	-	0.14
Current Income Taxes Payable	0.8	1.93	1.13	0.76	0.34	0.55
Other Current Liabilities	6.05	18.04	7.27	3.88	1.26	6.92
Total Current Liabilities	62.42	72.91	40.96	46.42	65.72	48.09
Long-Term Leases	-	-	-	-	0.32	-
Long-Term Deferred Tax Liabilities	0.3	0.32	0.59	0.91	1.21	1.53
Other Long-Term Liabilities	5.35	0.56	0.9	1.6	0.6	2.39
Total Liabilities	68.07	73.78	42.45	48.92	67.85	52
Common Stock	117.31	117.29	55.86	40.92	35.88	30.21
Additional Paid-In Capital	-	2,454	1,674	1,211	1,022	702.05
Retained Earnings	-	-1,442	-1,274	-962.65	-674.23	-377.75
Comprehensive Income & Other	681.35	-	-	-	-	-
Shareholders' Equity	798.66	1,129	455.39	289.08	383.32	354.51
Total Liabilities & Equity	866.72	1,203	497.84	338.01	451.17	406.52
Total Debt	-	-	-	0.07	0.32	0.14
Net Cash (Debt)	835.84	1,156	482.77	261.68	371.16	318.6
Net Cash Growth	119.71%	139.45%	84.49%	-29.50%	16.50%	20.49%
Net Cash Per Share	3.65	8.45	5.00	3.62	5.33	5.87
Filing Date Shares Outstanding	234.61	234.58	111.72	81.85	71.76	71.76
Total Common Shares Outstanding	234.61	234.58	111.72	81.85	71.76	60.42
Working Capital	802.89	1,130	454.64	223.37	312.21	279.76
Book Value Per Share	3.40	4.81	4.08	3.53	5.34	5.87
Tangible Book Value	798.66	1,129	453.17	220.98	315.89	283.76
Tangible Book Value Per Share	3.40	4.81	4.06	2.70	4.40	4.70
Machinery	-	0.15	0.15	0.15	0.15	0.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.